AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD)

CUSIP: 03152W109

Q3 2024 13F Holders as of 30 Sep 2024

Holder snapshot 7 signals
Share change
-7,295,414
Put/Call ratio
161%
SEC-reported price per share
$10.68
Number of holders
289
Value change
-$75,379,629
Number of buys
142
Open additional details 1 more signal available
Number of sells
117
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
316,644,581

Security key

03152W109

Report period

Q3 2024

Institutions

289

Top holders

10

Ownership snapshot

Top reported holders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
30 Jun 2024
13F Highest disclosed value: $283,598,972 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC has the largest disclosed position value at $283.6M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value Top 5
VANGUARD GROUP INC $283.6M
PERCEPTIVE ADVISORS LLC $278.33M
Avoro Capital Advisors LLC $271.81M
BlackRock Finance, Inc. $241.77M
WELLINGTON MANAGEMENT GROUP LLP $209.39M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$283,598,972
28,588,606 shares
— 30 Jun 2024
PERCEPTIVE ADVISORS LLC
13F
Company
13F
—
denominator unverified
$278,329,964
28,057,456 shares
— 30 Jun 2024
Avoro Capital Advisors LLC
13F
Company
13F
—
denominator unverified
$271,808,000
27,400,000 shares
— 30 Jun 2024
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$241,766,856
24,371,659 shares
— 30 Jun 2024
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
—
denominator unverified
$209,390,795
21,107,943 shares
— 30 Jun 2024
JPMORGAN CHASE & CO
13F
Company
13F
—
denominator unverified
$147,518,139
14,870,780 shares
— 30 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
289
Shares
309,836,000
Rows available
289
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
256
Q3 2024 holders
289
Holder diff
33
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 value Q3 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .